News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
In the Media News & Stories
In the Media, Staff/Faculty Update
Stewart elected to AACR board of directors
Sheila A. Stewart, PhD, associate director for basic science and co-leader of the Mechanisms of Cancer Biology Program at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been elected to the American Association for Cancer Research (AACR) Board of Directors. Stewart, who is also the Gerty Cori Professor and vice chair of the […]
In the Media
Hockey and Hope: Siteman teams up with St. Louis Blues alumni for third annual benefit game
Led by Kelly Chase, the March 27 event brings NHL legends and special guests together to raise funds for cancer research, patient care and lifesaving advances. Siteman Cancer Center is honored to once again be a beneficiary of the annual St. Louis Blues alumni game led by Kelly Chase, returning for its third year on […]
In the Media, Research, Staff/Faculty Update
Grant furthers novel therapeutic approach to glioblastoma
Mosquito-borne Zika virus helps destroy deadly brain cancer in mice Milan G. Chheda, MD, an associate professor of medicine in the Division of Oncology at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, […]
Clinical, In the Media, Research
FDA Breakthrough Therapy Designation Reflects Practice-Changing Trends Only at Siteman
Recognition follows strong early clinical results for a novel off-the-shelf CAR T therapy targeting rare and aggressive T-cell malignancies A novel off-the-shelf CAR T-cell therapy pioneered at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is gaining national recognition after delivering striking clinical results in patients with rare and aggressive blood cancers. The FDA […]
In the Media
FDA grants breakthrough therapy designation to treatment for rare blood cancers
Recognition follows strong early clinical results for a novel off-the-shelf CAR T therapy targeting rare and aggressive T-cell malignancies A novel off-the-shelf CAR T-cell therapy pioneered at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is gaining national recognition after delivering striking clinical results in patients with rare and aggressive blood cancers. The FDA […]
In the Media, Research
Siteman Cancer Center announces 2026 American Cancer Society-funded pilot projects
WashU Medicine grant recipients will focus on lung and blood cancers Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, is pleased to announce the next cohort of pilot projects funded by the Institutional Research Grant from the American Cancer Society. The three projects are described below. Under the leadership of Jason Weber, PhD, […]
In the Media, Research
New imaging approach reduces unnecessary breast biopsies by nearly 25%
WashU researchers at Siteman Cancer Center are advancing breast imaging to help patients avoid invasive procedures and improve the screening experience In a new discovery at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, a team of researchers and physicians found that utilizing ultrasound-guided diffuse optical tomography technology can reduce unnecessary breast biopsy rates by nearly […]
In the Media
Siteman Investment Program Awards $2.44 Million for Cancer Research
Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is pleased to announce funding for 13 new projects, including two clinical trials and community outreach and engagement efforts. Through this research, investigators aim to improve the understanding of tumor formation and growth, develop safer, more effective therapies, and remove barriers to precision medicine. The funding […]
In the Media, Patient Resource, Research
Siteman Kids is the first site of multicenter CAR-T trial for autoimmune diseases
Access to the novel immunotherapy — which “has the potential for cure” — is the latest offering by the national leader in pediatric hematology, oncology, and cell therapies. Siteman Kids at St. Louis Children’s Hospital, along with WashU Medicine, is the first site to test a novel immunotherapy drug for the treatment of autoimmune diseases […]
In the Media
Ghobadi appointed Director of Cellular Therapies at Siteman
Armin Ghobadi, MD, a WashU Medicine professor of medicine and bone marrow transplant specialist, has been named director of cellular therapies at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine. The new position formalizes his role as leader of clinical care and clinical research activities related to cellular therapy in the Hematologic Malignancies […]